Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients

PURPOSE: Chemotherapy (CTX) is an important part of the treatment strategy of stage II–IV ovarian cancer. CTX modifications, such as delays, dose reductions or premature terminations might have a negative impact on overall survival (OS) and progression free survival (PFS). The goal of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatsy, Sandra, Brambs, Christine, Kiechle, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147744/
https://www.ncbi.nlm.nih.gov/pubmed/36326848
http://dx.doi.org/10.1007/s00404-022-06813-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147744/
https://www.ncbi.nlm.nih.gov/pubmed/36326848
http://dx.doi.org/10.1007/s00404-022-06813-9

Ejemplares similares